Raymond  Dattwyler, M.D. - New York Medical College. Valhalla, NY, US

Raymond Dattwyler, M.D. Raymond  Dattwyler, M.D.

Professor of Medicine, Division of Clinical Immunology, Allergy and Rheumatology | New York Medical College

Valhalla, NY, US

Professor of Medicine, Chief of Division of Clinical Immunology, Allergy and Rheumatology

Media

Publications:

Raymond  Dattwyler, M.D. Publication Raymond  Dattwyler, M.D. Publication Raymond  Dattwyler, M.D. Publication

Documents:

Photos:

Raymond  Dattwyler, M.D. Photo Raymond  Dattwyler, M.D. Photo

Videos:

Audio:

Social

Biography

The Division of Clinical Immunology, Allergy and Rheumatology addresses the full range of immunologically mediated disease. It consists of four full-time physicians, two clinical immunologists/allergists and two rheumatologists who care for patients with an array of immunologic disorders: allergic diseases, asthma, allergic rhinitis, immunodeficiency and food allergy. Rheumatologic disorders comprise rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, Lyme arthritis and a full range of other less common or more difficult to diagnose musculoskeletal and connective tissue diseases. Members are involved in direct patient care, training of medical students, residents, fellows and practicing physicians, and research aimed at improving the health of people in general.

Dr. Dattwyler’s research aims to develop new diagnostic tests for infectious diseases, including Lyme disease. These new tests will lead to earlier diagnosis of Lyme disease and enable prompt treatment that may prevent the development of serious symptoms, such as arthritis and neuroborreliosis.

Research, both clinical and translational, bridges the gap between basic science research and clinical medicine. With funding from the NIH, Dr. Dattwyler’s group is working to develop new diagnostic tests for a number of infectious diseases, including Lyme disease. The new Lyme tests are designed to fill the gaps that exist in testing today, particularly for the early diagnosis of Lyme disease.

A new oral vaccine technology in development would have an array of potential uses, from protection against infectious diseases to treatment for food allergy. The CDC is sponsoring field trials to determine if an oral bait vaccine against Lyme disease can help control its spread in wildlife and the ticks that feed on them, thereby reducing the tick population that spreads Lyme bacteria to humans. The oral vaccine technique is also under study as a possible means of protection against other bacterial infectious diseases.

Industry Expertise (8)

Education/Learning Health and Wellness Health Care - Providers Health Care - Services Medical Devices Medical/Dental Practice Research Biotechnology

Areas of Expertise (6)

Molecular Biology Cell Biology Science Clinical Immunology Allergy and Rheumatology Lyme Disease Research

Education (3)

Mayo Clinic: Fellowship, Immunology

University of Wisconsin Hospital: Internship, Internal Medicine

S.U.N.Y Health Science Center: M.D., Medicine

Affiliations (3)

  • Clinical & Laboratory Immunology
  • American Board of Allergy & Immunology
  • American Board of Internal Medicine

Media Appearances (2)

Few docs recognize "chronic" Lyme disease

Reuters  online

2010-10-22

Lyme expert Dr. Raymond Dattwyler, of New York Medical College, said he wasn't surprised by the poll results. "Chronic Lyme disease is just not accepted by the vast majority of physicians," he told Reuters Health. "The majority of people who get the diagnosis of chronic Lyme disease have either depression, fibromyalgia or another chronic illness."...

view more

Ticked at The Times : I Had Lyme!

The Observer  

2001-07-16

The worst thing I’ve ever been told came from the lips of a doctor at the State University of New York at Stony Brook Medical Center in June 1998. “You have neurological damage,” said Patricia Coyle, a neurologist in her mid-40’s who specializes in Lyme disease. She seemed tired and overworked as she read from my latest medical tests and 10-year history of misdiagnoses. “The Lyme spirochete has crossed into your central nervous system and affected the blood flow in your brain,” she said. “It’s affected your ability to think, speak, reason and remember.”...

view more

Articles (selected) (5)

A Commentary on the Treatment of Early Lyme Disease
Oxford Journals

2010

ABSTRACT: The question of how long to treat Borrelia burgdorferi infection is a topic that provokes confusion among a large number of physicians. As pointed out by Kowalski et al in this issue of Clinical Infectious Diseases many physicians tend to use longer courses of antibiotics for Lyme disease than they would for other bacterial infections...

view more


The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America
Clinical Infectious Diseases

2006

ABSTRACT: Evidence-based guidelines for the management of patients with Lyme disease, human granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and babesiosis were prepared by an expert panel of the Infectious Diseases Society of ...

view more


Practice guidelines for the treatment of Lyme disease
Clinical Infectious Diseases

2000

ABSTRACT: Tick bites and prophylaxis. The best currently available method for preventing infection with Borrelia burgdorferi is to avoid vector tick exposure. If exposure to Ixodes scapularis or Ixodes pacificus ticks is unavoidable, measures recommended to ...

view more


Four clones of Borrelia burgdorferisensu stricto cause invasive infection in humans
Infection and Immunity

1999

ABSTRACT: Lyme disease begins at the site of a tick bite, producing a primary infection with spread of the organism to secondary sites occurring early in the course of infection. A major outer surface protein expressed by the spirochete early in infection is outer surface protein ...

view more


Seronegative Lyme disease
New England Journal of Medicine

1988

ABSTRACT: The diagnosis of Lyme disease often depends on the measurement of serum antibodies to Borrelia burgdorferi, the spirochete that causes this disorder. Although prompt treatment with antibiotics may abrogate the antibody response to the infection, symptoms ...

view more


 Your profile is not published.

Contact